Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of cylindrospermopsin, chlorpyrifos and their combination in a SH-SY5Y cell model concerning developmental neurotoxicity.

Ecotoxicology and environmental safety·2023
Same author

Evaluation of mRNA markers in differentiating human SH-SY5Y cells for estimation of developmental neurotoxicity.

Neurotoxicology·2023
Same author

Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.

Drug metabolism and disposition: the biological fate of chemicals·2020
Same author

Use of Segregated Hepatocyte Scaling Factors and Cross-Species Relationships to Resolve Clearance Dependence in the Prediction of Human Hepatic Clearance.

Drug metabolism and disposition: the biological fate of chemicals·2019
Same author

Clearance Prediction Methodology Needs Fundamental Improvement: Trends Common to Rat and Human Hepatocytes/Microsomes and Implications for Experimental Methodology.

Drug metabolism and disposition: the biological fate of chemicals·2017
Same author

Acrylamide affects proliferation and differentiation of the neural progenitor cell line C17.2 and the neuroblastoma cell line SH-SY5Y.

Toxicology in vitro : an international journal published in association with BIBRA·2016
Same journal

PM<sub>2.5</sub> exposure impairs mitochondrial function and myocardial contractility in cardiac organoids via the Sirt3/Mdh2 pathway.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same journal

Evaluation of an in-vitro test protocol using a three-dimensional human buccal oral mucosal model to assess the oral medical devices.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same journal

Descriptive oxidative and lipid-related fluorescence observations associated with Esketamine treatment in a high-concentration NMDA-exposed HT-22/C8-D1A co-culture model.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same journal

Integration of label-free electrochemical sensing, differential privacy deep learning, and blockchain for secure cytotoxicity monitoring.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same journal

Pulmonary permeability assessment using two human lung epithelial cell models in air-liquid interface cultures.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same journal

In vivo toxicity of some cyanide-containing compounds in zebrafish (Danio rerio) embryos.

Toxicology in vitro : an international journal published in association with BIBRA·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

An Integrated Approach to the Prediction of Systemic Toxicity using Computer-based Biokinetic Models and Biological

J Dejongh1, A Forsby, J B Houston

  • 1Research Institute of Toxicology (RITOX), Utrecht University, PO Box 80176, 3508 TD Utrecht, The Netherlands.

Toxicology in Vitro : an International Journal Published in Association with BIBRA
|July 27, 2010
PubMed
Summary
This summary is machine-generated.

This study integrates in vitro data with physiologically-based biokinetic models to estimate chemical neurotoxicity. Results show promising accuracy for risk assessment, guiding future research in chemical safety.

More Related Videos

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Related Experiment Videos

Last Updated: Jun 10, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

Area of Science:

  • Toxicology
  • Computational Biology
  • Pharmacokinetics

Background:

  • Assessing chemical neurotoxicity is crucial for public health.
  • Existing methods often rely heavily on animal testing.
  • Integrating in vitro data with computational models offers a potential alternative.

Purpose of the Study:

  • To estimate chemical neurotoxicity by combining in vitro studies with physiologically-based biokinetic models.
  • To evaluate the accuracy of these integrated models against in vivo data.
  • To identify key areas for future research in chemical risk assessment.

Main Methods:

  • Performed in vitro studies on general and specific neurotoxicity.
  • Modeled biokinetic behavior using biotransformation and tissue-blood distribution data.
  • Integrated in vitro results with physiologically-based biokinetic models for eight neurotoxic compounds.

Main Results:

  • Estimated lowest-observed-effect levels (LOELs) for eight neurotoxic compounds.
  • Discrepancy between estimated and experimental LOELs ranged from 2- to 10-fold.
  • LOEL estimates were more accurate for less toxic compounds; highly toxic compounds required additional in vitro data.

Conclusions:

  • The integration of in vitro studies and computer simulations shows encouraging results for chemical risk assessment.
  • This approach provides a foundation for developing more predictive and ethical toxicity testing strategies.
  • Further research is needed to refine models for highly toxic substances and expand the range of tested chemicals.